Both CB1 and CB2 specific elements control neuropathic nocic

Both CB2 certain systems and CB1 curb neuropathic nociception evoked by traumatic nerve injury. Larger clinical trials are ongoing. Heat shock protein gene and protein aggregation: Histone deacetylase inhibitors inductors Sodium phenylbutyrate Sodium phenylbutyrate increases transcription and posttranscriptional pathways, by inhibiting histone deacetylase enzyme. Consequent abnormal protein aggregation and transcription dysregulation may play a role in the pathogenesis of ALS. Ubiquitin cytosolic inclusions E2 conjugating certainly represent among the pathologic feature of ALS. 8 Within the mouse type of ALS salt phenylbutyrate promoted cell survival, alone or in conjunction with riluzole. A recently available 20 week openlabel study discovered that the oral administration of sodium phenylbutyrate to 26 ALS patients was safe and tolerable. 146 Blood histone acetylation levels were significantly improved after salt phenylbutyrate management, even at the lowest dose. 146 Further animal studies and clinical trials Metastasis on long-term safety and efficacy are needed. Valproic acid Valproic acid is a well known antiepileptic drug that’ll modulate transcriptional dysregulation by acting as a histone deacetylase inhibitor. It also may upregulate the antiapoptotic protein Bcl 2. Preclinical studies on SOD1 mutant mice gave discordant benefits, C152 some studies found that it prolongs survival when given before or at symptoms onset, while the others did not. More over, a recent sequential clinical trial discovered that treatment with valproic acid, in a dose utilized in epilepsy, is safe but does not show an excellent impact on survival or disease progression in 163 patients with ALS. 153 Other clinical trials are underway. 24 Scriptaid natural compound library Scriptaid is really a small molecule that serves as a histone deacetylase inhibitor. In vitro studies found that treatment with scriptaid disrupts aggresome formation in cultured cells transfected with mutant SOD1. 154 Trials on safety and efficacy of this compound both in ALS patients and animal models remain unavailable. Arimoclomol Arimoclomol induces heat shock protein all through cell stress and increases heat shock protein gene expression. This drug may hinder apoptosis and protein aggregation, systems apt to be involved in ALS pathogenesis. It somewhat prolonged survival in SOD1 rats, when given either ahead of the onset or in the symptoms onset. In a current early-stage clinical trial it had been administered orally at three different dosages to 84 patients with ALS over 12 weeks. The drug showed well-tolerated and safe effects at doses up to 300 mg/day. An effectiveness study in ALS patients has been planned but isn’t yet open for recruitment, because the drug has been added to hold by the FDA until results of pre-clinical toxicology studies become available.

Studies particular for Flt 3 Cmutated individuals and in con

Reports particular for Flt 3 Cmutated patients and in combination with standard 7 3 treatment are ongoing. CR charges among age 60 years and 60 years were 39. Four to five and 43. 60-pound, respectively, among previous and tAML MDS, the CR rates were 44 and 400-page. 2%, respectively, for patients with intermediate and bad cytogenetics, the CR rates were 61. 1% and 23. 2 months, respectively. This study showed that amonafide Bosutinib solubility in combination with cytarabine created sturdy responses and a higher CR rate in both older and younger patients with secondary AML. Gemtuzumab ozogamycin is really a monoclonal antibody GO against CD33 conjugated to calichemycin. Mylotarg was granted accelerated approval in May possibly 2000 as second-line therapy for patients 60 years or older with CD33 ng AML have been not candidates for chemotherapy. Pfizer lately withdrew the drug from the market because of a high death rate in postmarket studies. Besides, no profit for progression free survival or OS was seen with the addition of Mylotarg to typical daunorubicin or Ara D induction. Cell Cycle Inhibitors ON 01910 ON 01910. Na is just a small molecular weight compound that has a multitargeted mechanism of action, resulting in a particular mitotic block and Retroperitoneal lymph node dissection cell death in cancer cells. In particular, the polo like kinase pathway is affected, producing polynumeric centrosomes and dysregulation of mitosis. At the molecular level, ON 01910. Na also inhibits PI 3 kinases. In ON 01910 Ctreated cells, both ERK and AKT pathways are inhibited. Following G2/M arrest, cells endure apoptosis via the caspase pathway. One of the remarkable actions observed for this compound is action in drug-resistant cancer cells and in tumor cells with antiapoptotic limitations. PLKs now appear that you can targets in future anticancer therapy. Connections between PLK 2 and the AML/ETO hybrid molecule in t AML appear to mediate antiapoptotic effects. A period I/II study of ON 01910. Na is being performed in patients with hematological malignancies. This research has Anastrozole ic50 shown that ON 01910. Na seems to be safe and well tolerated in individuals with refractory or relapsed AML and MDS. ON 01910. Na has biological activity with reduction in bone marrow blasts, removal of the MDS clone, and development in the peripheral blood counts in certain patients in stage I and II trials. These effects are associated with increased survival, although in limited numbers of patients treated thus far. A pivotal phase III trial of ON 01910 in MDS patients has become underway. A single agent phase I study in refractory AML patients is assessing single agent exercise as a prelude to combination therapy studies. Further study of ON 01910. Summary and prospect The major improvements in AML treatment over the past 2 years have not been the introduction of new therapeutic agents but instead the more optimal use of well known drugs.

Membranes were again washed 3 times in Tris buffer saline T

Walls were again washed 3 times in Tris buffer saline T and developed using ECL substrate. Cancer stem cells migrate in to the damage area as single cells in the sides. RNA isolation and mRNA expression analysis Total RNAs were separated using Docetaxel structure the RNeasy Mini Kit. Supporting DNAs were synthesized by oligo priming techniques. Realtime PCR was performed utilising the SYBR Green Supermix in line with the manufacturers directions. Primers specific for each of the signaling molecules were used to generate the PCR products and created using NCBI/Primer BLAST. Expression levels of glyceraldehyde 3 phosphate dehydrogenase were useful for normalization and quantification of gene expression levels. For the quantification of gene amplification, real time PCR was performed using an ABI 7300 Sequence Detection System in the presence of SYBR Green. The following genespecific primers were used: Gli reporter assay Gli reporter activity was measured as we described elsewhere. 53 In short, cop GFP and luciferase genes were cloned downstream of Gli answer factor, containing four Gli binding motifs. Prostate CSCs were transduced with lentiviral particles and steady Lymphatic system cells were selected. For transcription analysis, CSCs were seeded in 12 well plates and treated with or without NVP LDE 225 for up to 48 h. After incubation, CSCs were collected and analyzed for luciferase reporter activity. Immunocytochemistry Prostate CSCs were developed on fibronectin coated coverslips in the presence or absence of NVP LDE 225. Consequently, cells were fixed with 4% paraformaldehyde for 15 min, permeabilized with 0. 1% Triton X 100 in 1 PBS, cleaned and blocked in 10% normal goat serum. After washing with PBS, cells were stained with Gli1 and Gli2 major antibodies for 16 h at 4 1C and washed with PBS. Afterward, cells were incubated with fluorescently labeled secondary antibody along with DAPI for 1 h at room temperature. Eventually, supplier Capecitabine coverslips were washed and mounted using Vectashield. Isotype particular negative controls were incorporated with each staining. Stained cells were visualized and installed under a fluorescent microscope. Once we described elsewhere imunohistochemistry of prostate cancer cells was done. Antitumor activity of NVP LDE 225 Human prostate CSCs were injected subcutaneously into the flanks of NOD/SCID IL2Rgnull mice. After 2 weeks of CSC implantation, rats were handled with NVP LDE 225 intraperitoneally three times each week for 4 weeks. At the end of the test, mice were euthanized, and cancers were isolated for bio-chemical analysis. Statistical analysis The mean and s. d. were determined for every experimental group. Differences between groups were examined by a couple of way analysis of variance, followed by Bonferonis multiple comparison tests applying PRISM statistical analysis pc software. Significant differences among groups were calculated at Po0. 05.

The effect of chronic administration of cannabinoids to the

The effect of chronic administration of cannabinoids on the survival of G93A rats was next examined. Recent evidence suggests that ALS is a disease characterized by chronic inflammation. Moreover, CB2 receptors are up-regulated in the target cells of several neuroinflammatory diseases. The primary Ganetespib cost site of pathology in ALS patients is the spinal-cord, with participation of lower brain stem areas late in the illness process. In G93A rats, CB2 receptor mRNA is selectively up regulated in the back in a temporal pattern directly paralleling illness development. More over, increased mRNA levels are correlated with increased CB2 receptor protein levels in the spinal cords of end stage G93A rats. These results suggest that, just like other neuroinflammatory disorders, the different parts of the cannabinoid system are selectively altered inside the target structure related to ALS pathogenesis. In addition, low levels of both CB2 receptor mRNA and protein noticed in WT OE spinal cables described here come in agreement with recent studies demonstrating the presence of functional CB2 receptors in the CNS of mice. Drugs which trigger CB2 receptors, effectively enhance the outward indications of a few inflammatory diseases including abdominal hypermotility as a result of Retroperitoneal lymph node dissection multiple sclerosis, atherosclerosis, endotoxic shock and Alzheimer s infection. Recent in vitro studies show that CB2 receptors are up regulated in microglia in response to inflammatory stimuli and that CB2 agonists reduce microglial activation. In our study, we demonstrate that not only are CB2 receptors considerably up regulated in the spinal cords of characteristic G93A rats, they are also in a position to functionally encourage G proteins when activated by agonists. Specifically, we suggest that in the first stages of motor neuron degeneration, CB2 receptors and endocannabinoids are CTEP selectively up regulated in spinal microglia as a compensatory, protective measure to reduce inflammation. Contrary to the above hypothesis, it’s important to note that a minimum of one study has suggested that the CB2 particular agonist AM 1241 might behave as a protean agonist, showing villain, inverse agonist or partial agonist activity with regards to the assay and/or tissue examined. Furthermore, in our study, AM 1241 produced little to no stimulation of G proteins in symptomatic G93A spinal cord membranes. Although the absence of agonist activity described here might be the result of less than optimal experimental conditions, it is also possible that the beneficial effect of AM 1241 in this animal model might instead result from antagonism of CB2 receptor activation produced by the endogenous cannabinoid agonists 2 arachido noyl glycerol and/or anandamide, regarded as elevated in the spinal cords of systematic G93A rats.

Analysis of cell survival demonstrates increased expression

Analysis of cell survival suggests that increased expression of either WT or A53T HuS lead to increased vulnerability of the cells to ER stresses. To determine if chronic ERS associated toxicity is mechanistically linked to the beginning and/or progression of disease in vivo, we treated cohorts of A53TS Tg mice with Salubrinal, a compound known to guard cell from chronic ER stress by inhibiting dephosphorylation of eIF2. Salubrinal has been proven to partially attenuate PC12 cells from A53T S dependent accumulation and to increase lifespan of G93A SOD1 Tg mouse type of Motor Neuron Disease CTEP by 20 days. Hence, if long-term ER stress can be an necessary and effective participant in synucleinopathy, Salubrinal can attenuate the condition manifestation in rats. Moreover, having less p eIF2 induction in the A53TS Tg mouse model provides further reason for using Salubrinal. Since the A53TS Tg mouse model used here is one of the few models of critical synucleinopathy, as it will be in humans, the expected life was used as the main outcome measure for the potential therapeutic effects of Salubrinal on synucleinopathy. To be able to minmise any adaptive Cholangiocarcinoma effects of treatment, Salubrinal treatment was started at 12 weeks old. At this age, the disease had been developed by 20% of A53TS Tg mice cohorts in various groups at the exact same rate. However, following the initiation of Salubrinal treatment, the pace of disease onset in the Salubrinal party was obviously slower than the control cohort. Analysis of brain extracts from vehicle and Salubrinal treated mice suggests that while Salubrinal therapy did not consistently cause increase in p eIF2 levels, there clearly was substantial and steady increase in the levels of CHOP phrase, a reporter of p eIF2. To determine if the Salubrinal treatment immediately influences S appearance or development of S problems, the brain lysates were analyzed for S levels. The outcomes show Tipifarnib molecular weight that the levels of overall SDS soluble S were not affected by the Salubrinal therapy, confirming that Salubrinal did not simply reduce total S phrase. Nevertheless, Salubrinal treatment was associated with dramatically paid off microsomal deposition of monomeric and oligomeric S. More over, our spouse evaluation for toxic S oligomers suggests that Salubrinal therapy attenuates the accumulation of toxic S oligomers. Salubrinal treatment didn’t attenuate the development of the disease following onset, while Salubrinal treatment delayed the onset of motoric signs. Thus, immunocytochemical evaluation of endstage Tg mice for that accumulation of pSer129 S or other neuropathology did not show obvious differences between the Salubrinal and vehicle treated mice. Moreover, our results claim that anti ER pressure materials, including Salubrinal, should be created as a treatment for synucleinopathy.

Process is supported by observations on the rate of transfer

Process is supported by observations on the rate of transfer of metal from pre-formed Fe DFP processes to 10 uM DFO which present transfer of Fe to become complete in 1. 5 hours. This suggests that, even though the iron citrate rates in this in vitro system resemble those found in serum, additional kinds of iron might be present in serum as NTBI. This is also indicated by differences in the response of the slow rate to temperature change in DFO entry to NTBI in Icotinib serum and in iron citrate. Previous work implies that, under the circumstances of these tests, dimers and monomers of ferric citrate will predominate with some little oligomers also present 6. Current aqueous speciation of ferric citrate using mass spectrometry and EPR spectroscopy has confirmed that the most appropriate species are a monoiron dicitrate species and dinuclear and trinuclear oligomeric buildings, the relative concentration of which is dependent on the iron: citric acid molar ratio 7. In iron over-loaded plasma however, the presence of plasma proteins and oxidants might like a polymerization of iron citrate species, even Plastid at these iron : citrate ratios. We have previously found that DFO interacts more slowly with metal coordinated to proteins and resource nutrients compared to small neutrally charged DFP, by virtue of the bigger dimension and hexadentate coordination chemistry of DFO 39, and these rules could also explain the slower and incomplete access of DFO to NTBI we observed in serum. Evidence for interaction of NTBI with plasma proteins has been obtained from the decreased filterability of iron citrate through 30 Kda molecular-weight cut off filters in the existence of clinically relevant concentrations of albumin 6, 40. Surprisingly however, the experiments performed here with human albumin showed that chelation of iron from citrate alternatives is clearly enhanced by the presence Letrozole 112809-51-5 of albumin, achieving completion in 4h with DFO compared to more than 20 h for the iron citrate without albumin. Just like iron citrate solutions, the formation of FO is temperature dependent and enhanced by DFP. Moreover, as with simple iron citrate answers, company incubation of DFP substantially superior FO formation at an interest rate that was practically equivalent to that measured for DFP alone again consistent with DFP shuttling iron onto FO. This does not explain why NTBI from the serum from thalassemia individuals is fairly inaccessible to chelation by DFO. This apparent paradox could be explained by recent work indicating that in plasma from individuals with iron overload or diabetes, low enzymic modifications to albumin occur, developing glycated adducts that bind iron more closely than unmodified plasma albumin 8.

Nitroprusside had no significant effect on size or diameter

Nitroprusside had no significant impact on visualized length or height of the coronary artery branches. Coronary CTA is advantageous for the anatomic interpretation of coronary artery branches in the dog. dog, heart, MDCT Multi-detector computed tomography coronary artery angiography is promoted for noninvasive assessment Letrozole Aromatase inhibitor of the coronary arteries in characteristic human patients. 1 Coronary CTA has been largely helped by the introduction of EKGgated MDCT2 and enables visualization of the whole coronary artery tree. 3,4 The usage of 64 MDCT has enhanced exposure and image quality of small coronary artery branches weighed against 16 MDCT. 5 Also, coronary CTA has been employed for the characterization and identification of anomalous coronary arteries which, in humans, may demonstrate malignant alternatives potentially vulnerable to minimal exercise capability and/or sudden death. Variations in individual physiology, such as for example anomalous coronary arteries in Bulldogs, are important, 6 Even though obstructive coronary artery infection as noticed in human patients isn’t observed frequently in dogs. 7 9 Such variants must be recognized before pulmonic device mechanism dilation as diminished coronary blood flow or avulsion of the coronary artery can result in death. 10 Currently, selective Gene expression catheter angiography may be the gold-standard for canine coronary angiography. This is invasive and has the potential of negative effects. It remains used in settings where understanding of the span of the vessels is critical. There’s paucity on the anatomic information, diagnostic effectiveness and quality standards, together with the influence of vasodilating medications in canine coronary CTA 10 Although there are information on canine coronary CTA in basic translational research,11. Consequently, our goal was to check the feasibility of 64 MDCT for creation of canine coronary arteries. an anesthetic method without and with injectable sodium nitroprusside, a coronary and pulmonary vasodilator, was compared Bortezomib Proteasome inhibitor for this function. General anesthesia was induced in four 1-year old Beagle dogs with propofol and maintained with isoflurane in a large number of oxygen administered via orotracheal tube. Conclusion tidal carbon dioxide levels were maintained between 35 and 45 mmHg using a mechanical ventilator. For specific runs apnea was caused by hyperventilation immediately before the check. Intravenous crystalloid solution was administered via a 22 G catheter in the left cephalic vein at 10 ml/kg/h with liquid boluses of 5 ml/kg as essential to maintain blood pressure. Esmolol was also used through this catheter in a attempt to lessen heart rate through B 1 adrenergic receptor antagonism. In each puppy, a 100 ug/kg bolus was given accompanied by an infusion of 50 ug/kg/min. However, since heart rate did not reduce, the infusion was enhanced every 5 min to no more than 300 ug/ kg/min. Scans were started within 15 min following the onset of esmolol infusion.

T Smad2 and p Smad2 were found by using mouse anti T Smad2 a

T Smad2 and p Smad2 were found by using mouse anti T Smad2 and rabbit anti p Smad2 main antibodies followed by the corresponding secondary antibodies. The femurs were then Conjugating enzyme inhibitor subjected to micro CT analysis and subsequent bone histomorphometric analysis of undecalcified sections, following previously established standards. Because some evaluations will be done between the femurs and tumor bearing femurs, we performed a pilot study in which we inserted growth medium intrafemorally into 4 rats to evaluate if the inoculation treatment caused any clear histologic change due to bone remodeling. One month after the procedure in the distal end of the femur, we did not find any apparent histologic alteration. This will be the result of our having used a really small hook to drill a hole in the bone and the small volume we shot, this may be the same process we use to provide PCa cells. For x-ray analysis of tumefaction bearing bones, animals were anesthetized and placed in vulnerable and then lateral positions on the board. The board Lymph node was put against an x ray film, and the animals were subjected to x rays at 20 kV for 15 s in a Faxitron radiographic assessment unit. Subjected films were created in a automated movie processor, and the radiographs were assessed for the current presence of bone lesions. Micro CT analysis was performed in the Small Animal Imaging Facility at MD Anderson by having an Enhanced Vision Systems hybrid example protection at a resolution of 20 um. Images were calibrated in Hounsfield units with using a separately scanned water air bone phantom supplied by GE. Once reconstructions were performed, the volumes were Hedgehog inhibitor Vismodegib analyzed by using software provided by GE. A 3 mm mid-shaft area of cortical bone, recognized as the middle of each femur in accordance with the distal and proximal ends, was evaluated for each bone. Mice were euthanized at the end of the study period. Disarticulated left and right femurs were fixed by immersion in ten percent buffered formalin and subsequently prepared for examination of undecalcified sections in the Bone Histomorphometry Core service at MD Anderson according to previously established standards. The femurs were placed in order that sagittal 5 um thick sections may be obtained through the whole thickness of every bone. Slides were stained with toluidine blue for assessing osteoblast numbers and areas and with TRAP, an enzyme exclusively expressed by osteoclasts in the bone marrow, for assessing osteoclast variables. Both osteoblasts and osteoclasts were quantified on 25-30 adjacent high magnification fields obtained from representative 5 um tissue section, by using the OsteoMeasure application system. Two sample t testing for equal variance was used to spot the statistical significance of differences between the way of different treatment groups, g 0. 05 was considered statistically significant.

Metronidazole is only effective against anaerobic Mtb cells

Metronidazole is effective against anaerobic Mtb cells and its activity can be further improved in the presence of the transcriptional inhibitor RIF, which has reasonable capability against anaerobic Mtb, while addition of INH, which has no effect against anaerobic persisting Mtb, doesn’t potentiate the cidal effect of this nitroimidazole. Tissue penetration of 5 nitroimidazole class of materials is good Avagacestat solubility but isn’t specific. Therefore, metronidazole was distributed in pelvic tissues, teeth, peritoneal liquid pancreas, colorectal tissues in addition to in the central nervous system. In acute studies in rats, metronidazole was well tolerated without any reported serious toxicity problems up to 80 months in a dose of 150 mg/kg. Metronidazole is pretty well tolerated in humans because it is also one of the drugs that can be used throughout pregnancy, with very little reversible medical side effects. These factors are crucial for anti tubercular drug progress where chemotherapy is of extended duration and where noncompliance to treatment regimens as a result of adverse effects is really a significant problem in disease management. Metronidazole is tested in a scientific study of its effectiveness in the treatment of pulmonary TB in patients. In this study, people were treated with INH, RIF and streptomycin with or without metronidazole. It was unearthed that patients receiving Lymphatic system 400 mg of metronidazole three times daily showed changes as measured by radiographic improvement as well as overall well being over patients receiving placebo. Both metronidazole and placebo addressed patients showed similar sputum settlement rates, which measures lowering of the number of acid fast bacilli in the sputum during chemotherapy. This is simply not surprising since metronidazole is postulated to be ineffective hedgehog pathway inhibitor against the bacterial communities in cavities that have eroded in to the airways since these are thought to be aerobic or microaerophilic, while transcriptional profiling of sputum derived mycobacteria has indicated that these may result from hypoxic situations as shown by the upregulation of the dormancy reaction regulon. In vivo studies with nitroimidazo oxazoles group of compounds that were synthesized by Hindustan Ciba Geigy Ltd were performed in murine M. bovis disease. For most of the compounds, the in vitro activity wasn’t reflected in their in vivo potency, as seen, for example, using the spiro cyclohexyl by-product 47, which showed promising in vitro activity but was inactive in vivo. CGI 17341, which had an in vitro MIC value of 0. 32 uM and an in vivo ED50 of 7. 7 mg/kg was found to be active against ten clinical isolates and many drug resistant Mtb with MICs of 0. 43 1. 6 uM. Treatment of mice infected with Mtb after 11 and 12 days post illness with CGI 17341 showed activity of this element at a dose of 80 mg/kg for just two months.

The descriptor subsets of different sizes were optimized usi

The descriptor sub-sets of different sizes were improved using Leave one-out cross-validation procedure to obtain a number of models with acceptable qgreater than a certain limit. The training set models with acceptable qwere then confirmed on the test sets to choose predictive models with Rexceeding 0. 6. All through modeling, default parameters supplier Lapatinib were used unless otherwise stated. Furthermore, as a way to exclude the possibility of chance correlation, B randomization experiments were done three times, as described previously15,, for your training sets but with randomized permeability values. Due to the large diversity of the dataset, strict conditions were also used to guarantee the consistency of the forecasts with a small arbitrary applicability website, as revealed elsewhere, Ideal medicine candidates should be metabolically stable. To the end, MetaSitewas applied to identify the potential metabolic web sites of the materials and to design analogs with increased metabolic properties. Fleetingly, the software uses two factors to investigate the metabolic process likelihood of a site: the similarity between the CYP450 enzymes and the ligand, and the chemical reactivity of the substrate. The likeness analysis of the CYP450 enzyme interaction site and the substrate Plastid is completed through the calculation of two pieces of chemical fingerprints descriptors: the other one for the substrate and one for the CYP450 enzymes. Furthermore, the program considers the chemical reactivity of the substrate by considering of the activation energy necessary for production of reactive intermediates. The rating for likely metabolic websites is based on the above similarity analysis and chemical reactivity. 2Synthesis of the compounds was done as explained previously for compounds and respectively. Kand Kwere measured using surface plasmon resonance spectroscopy, and as previously described ICs for mobile inhibition of phospho Akt in BxPC 3 pancreatic cancer cells were measured. 31UNQ14 and 2UVM52 are Akt crystal structures supplier Cabozantinib obtainable in the PDB, co crystallized with the native ligand inositol tetrakisphosphate, and with benzene 1,2,3,4 tetrayl tetrakisphosphate, respectively. Both of these complex structures are very similar with RMSD 0. 64 for backbone atom RMSD 1 and position. 03 upon the all nuclear superimposition in the proteins. Thus, the structure 1UNQ, which includes the higher resolution, was employed for docking. So that you can keep the first binding mode of the ligand in the crystal composition, the x ray pose of the ligand in 2UVM was merged to the 1UNQ binding pocket for comparing x ray constructions and docked poses, as generally employed, 18. Looking algorithms are required to help you to taste the global minimum of the conformational space, and scoring features are required to rank because the best that pose.